Analyst consensus rating
Insmed Analyst Rating: Strong Buy
Direct answer
Insmed's consensus rating is Strong Buy.
22 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $194.18.
Forecast evidence checked November 14, 2026.
Get free Insmed email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $121.16
- Average price target
- $194.18
- High price target
- $243.00
- Low price target
- $158.00
- Low target gap
- +30.4%
- Target upside
- +60.3%
- High target gap
- +100.6%
- Target range width
- 70.2%
- Consensus rating
- Strong Buy
- Analysts
- 22
- Evidence date
- November 14, 2026
- Valid through
- November 21, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Insmed?
Insmed has a verified Strong Buy consensus. The same dataset has an average price target of $194.18.
How far are Insmed's low and high targets from the recorded price?
The low target implies +30.4%, while the high target implies +100.6%.
How many analysts are included in Insmed's consensus?
The verified consensus includes 22 analysts.
How is Insmed's target upside or downside calculated?
The average target of $194.18 is divided by the recorded price of $121.16, then one is subtracted to produce +60.3%. This does not guarantee a future return.
When was Insmed's analyst forecast verified?
The data was verified on 2026-11-14. The dataset is valid through 2026-11-21.